Biosense Webster showcased its portfolio of cutting edge innovative electrophysiology technologies at the 2013 Boston AF meeting.

 

 

In response to the astounding percentage of inappropriate and non-compliant ICD, CRT-P and CRT-D device implantations each year, Think Tank Medical has developed and released its CMS ICD Application, available for the iPhone and iPad to ensure that 100 percent of patients screened meet the evidence-based criteria for implantation.

TeraRecon received the North American New Product Innovation Award in Medical Imaging Informatics from the respected independent research firm Frost and Sullivan. This is the seventh time that TeraRecon Inc. has been recognized with a Best Practices award from Frost and Sullivan, and the third time since 2010, following the European Company of the Year Award in the category of Medical Imaging, Advanced Visualization Applications, and the North American Growth Leadership of the Year Award.


Boston Scientific received CE mark approval for the Promus Premier everolimus-eluting platinum chromium coronary stent system, the company's next-generation durable polymer drug-eluting stent (DES) technology. The Promus Premier is designed to improve DES performance with a new delivery system and redesigned stent architecture that improves radial, axial strength and deliverability.


As health systems are under increasing pressure to share data across systems to improve and expand their networks of care, CardioNet Inc. and AirStrip have entered into a partnership agreement to develop and co-market an integrated solution for mobile patient monitoring.

 

Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of its Advisa DR MRI (magnetic resonance imaging) SureScan pacing system. The Advisa MRI system is Medtronic’s second-generation MR-conditional pacemaker and is the first system to combine the most advanced pacing technology with proven MRI access.

Subscribe Now